首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1588566

全球流式細胞儀市場 - 2024-2031

Global Flow Cytometry Market - 2024-2031

出版日期: 2024年11月08日 | 出版商:

DataM Intelligence | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球流式細胞儀市場規模達到47.6億美元，預計2031年將達到82.4億美元，2024-2031年預測期間複合年成長率為7.1%。

流式細胞儀是一種識別和量化懸浮在液體介質中的細胞或顆粒的物理和化學特性的先進方法。這項技術能夠在單一細胞經過雷射光束時進行快速檢查，並根據其光散射和螢光特性進行照明和評估。

流式細胞儀是一種雷射驅動技術，可識別和測量細胞或顆粒的不同特徵，例如大小、粒度和使用螢光標記的特定蛋白質標記。這種方法可以讓醫療保健專業人員分析血液、骨髓和其他體液樣本。它對於透過檢測和表徵各種細胞類型來診斷癌症和感染等疾病特別有價值。

市場動態：

司機

慢性病發生率上升和技術進步

全球流式細胞儀市場的需求是由多種因素所驅動的。主要因素之一是慢性病發病率上升和技術進步。癌症、糖尿病和心血管疾病等慢性病的盛行率不斷上升，大大推動了對流式細胞儀等先進診斷工具的需求。早期診斷對於改善慢性病患者的治療效果至關重要。流式細胞儀可快速且準確地分析細胞特徵，使醫療保健專業人員能夠在早期階段檢測到異常情況。

此外，流式細胞儀技術的不斷進步，特別是高通量流式細胞儀（HTFC）和光譜流式細胞儀的出現，大大提高了資料解析度並促進更複雜的分析。 HTFC 能夠每秒檢查數千個細胞，這對於廣泛的研究工作至關重要。例如，HyperCyt 等系統可從多孔板快速加載樣品，每分鐘處理多達 40 個孔。這種快速通量對於藥物發現和篩選過程至關重要，其中快速分析大量樣品至關重要。

此外，行業產品發布和批准的主要參與者將推動該市場的成長。例如，2024 年 5 月，安捷倫科技公司推出了 NovoCyte Opteon 光譜流式細胞儀，標誌著流式細胞儀可及性的重大進步。這項創新系統為基礎研究、藥物發現和治療開發等各領域的流量資料取得、分析和報告建立了新的基準。

此外，IDEX Health & Science 於 2024 年 1 月推出了 Semrock 系列 Nanopede 濾光片，專為流式細胞儀應用而設計。 Nanopede 濾光片經過精心設計，可提供高傳輸率，同時有效阻擋整個光譜中不需要的光（光密度 OD5）。這確保了流式細胞儀期間收集的螢光訊號清晰準確。

同樣，2023 年 11 月，CD Bioarticles 宣布推出一系列新的流式細胞儀顆粒，其中包括專為流式細胞儀實驗校準和標準化而設計的各種類型的聚苯乙烯顆粒。

限制

設備成本高昂和個人缺乏意識等因素預計將阻礙市場的發展。

Flow cytometry is an advanced method to identify and quantify the physical and chemical traits of cells or particles suspended in a liquid medium. This technique enables the swift examination of individual cells as they move past a laser beam, where they are illuminated and evaluated based on their light scattering and fluorescence characteristics.

Flow cytometry is a laser-driven technique that identifies and measures different characteristics of cells or particles, such as size, granularity, and specific protein markers using fluorescent labeling. This method allows healthcare professionals to analyze blood, bone marrow, and other bodily fluids samples. It is especially valuable for diagnosing diseases like cancer and infections by detecting and characterizing various cell types.

Market Dynamics: Drivers

Rising incidence of chronic diseases and technological advancements

The demand for the global flow cytometry market is driven by multiple factors. One of the primary factors is the rising incidence of chronic diseases and technological advancements. The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is significantly driving the demand for advanced diagnostic tools like flow cytometers. Early diagnosis is essential for enhancing patient outcomes in chronic diseases. Flow cytometry provides quick and accurate analysis of cellular characteristics, allowing healthcare professionals to detect abnormalities at earlier stages.

Furthermore, continuous technological advancements in flow cytometry technology, particularly the emergence of high-throughput flow cytometry (HTFC) and spectral flow cytometry, are greatly improving data resolution and facilitating more intricate analyses. HTFC enables the examination of thousands of cells per second, which is vital for extensive research efforts. For instance, systems like HyperCyt allow for swift sample loading from multi-well plates, processing up to 40 wells every minute. This rapid throughput is essential in drug discovery and screening processes, where analyzing large quantities of samples quickly is crucial.

In addition, key players in the industry product launches and approvals that would drive this market growth. For instance, in May 2024, Agilent Technologies Inc. unveiled the NovoCyte Opteon Spectral Flow Cytometer, marking a significant advancement in flow cytometry accessibility. This innovative system establishes a new benchmark for acquiring, analyzing, and reporting flow data across various fields, including basic research, drug discovery, and therapy development.

Also, in January 2024, IDEX Health & Science launched the Semrock line of Nanopede Optical Filters, specifically designed for flow cytometry applications. The Nanopede filters are engineered to provide high transmission rates while effectively blocking unwanted light (optical density OD5) across the spectrum. This ensures that the fluorescence signals collected during flow cytometry are clear and accurate.

Similarly, in November 2023, CD Bioparticles announced the launch of a new range of Flow Cytometry Particles, which includes various types of polystyrene particles specifically designed for calibration and standardization in flow cytometry experiments.

Restraints

Factors such as high equipment costs, and lack of awareness among individuals, are expected to hamper the market.

Segment Analysis

The global flow cytometry market is segmented based on product type, technology, application, end-user, and region.

The reagents and consumables segment accounted for approximately 43.9% of the global flow cytometry market share

The reagents and consumables segment is expected to hold the largest market share over the forecast period. The reagents and consumables segment is a crucial element of the flow cytometry market, significantly contributing to its growth and application across multiple domains. This segment includes a variety of essential products for performing flow cytometry assays, such as antibodies, assays, kits, and various other reagents.

Moreover, key players in the industry have innovative product launches & approvals and technological advancements that would drive this market growth. For instance, in August 2024, Bio-Rad Laboratories, Inc. announced the launch of annexin V conjugated to eight StarBright Dyes: SBUV400, SBUV795, SBV440, SBV515, SBV790, SBB675, SBB765, and SBY800. These new Annexin V StarBright conjugates facilitate the detection of early apoptotic cells through flow cytometry and provide researchers with a broader selection of fluorophore options. This expansion enhances the ability to incorporate apoptosis detection into multicolor immunophenotyping panels for both conventional and full-spectrum flow cytometry applications.

Also, in May 2023, Sysmex Corporation launched its Clinical Flow Cytometry System, which includes the Flow Cytometer XF-1600 and Sample Preparation System PS-10, along with antibody reagents and related products in Japan. The introduction of the XF-1600 is anticipated to greatly enhance workflow efficiency in clinical laboratories by minimizing manual tasks and promoting standardization. This development aligns with Sysmex's dedication to improving diagnostic capabilities and tackling medical challenges through innovative solutions.

Similarly, in March 2024, Beckman Coulter Life Sciences received 510(k) clearance from the Food and Drug Administration (FDA) to distribute its DxFLEX Clinical Flow Cytometer in the United States. This development brings the widely used benchtop IVD flow cytometry system to American laboratories while enhancing their testing capabilities. The DxFLEX system supports up to 13 colors, and additional detectors can be activated as laboratory needs change, eliminating the necessity for new hardware purchases.

Geographical Analysis

North America accounted for approximately 44.8% of the global flow cytometry market share

North America region is expected to hold the largest market share over the forecast period owing to the growing prevalence of chronic diseases, especially cancer and immunodeficiency disorders, which is a significant factor driving the flow cytometry market. The American Cancer Society indicated that around 1.9 million new cancer cases would be diagnosed in the U.S. in 2022, which would drive the need for effective diagnostic tools like flow cytometry. As healthcare professionals increasingly seek faster and more precise diagnostic methods, the importance of flow cytometry continues to rise.

Technological advancements in flow cytometry are significantly enhancing its capabilities, leading to better resolution and sensitivity in quantifying different cell types. Innovations like multi-parameter analysis enable thorough immunophenotyping, which is vital for diagnosing and tracking diseases such as leukemia and lymphoma. Additionally, the launch of new instruments and software solutions is further driving market growth.

Moreover, in this region, a major number of key player's presence, well-advanced healthcare infrastructure, and government initiatives & regulatory support, and investment in research and development would drive this market growth. For instance, in June 2023, in New Jersey, BD (Becton, Dickinson and Company) announced the global launch of a new automated instrument designed for preparing samples for clinical diagnostics using flow cytometry. This innovative system facilitates a complete "walkaway" workflow solution aimed at enhancing standardization and reproducibility in cellular diagnostics.

Also, in May 2023, in New Jersey BD (Becton, Dickinson and Company) announced the global launch of an innovative cell sorting instrument that incorporates two innovative technologies, significantly enhancing the capabilities of flow cytometry.

Market Segmentation

By Product Type

Reagents and Consumables
- Antibodies
- Assays and kits
- Others
Instruments
- Cell Analyzers
- Cell Sorters
Software
Accessories
Services

By Technology

Cell-Based
Bead-Based

By Application

Research
- Drug Discovery
- Stem Cell Research
- Immunology Studies
- Apoptosis Analysis
- Cell Sorting and Viability Assessments
Clinical
- Cancer Detection
- Organ Transplantation
- Immunodeficiency Disorders
- Hematology
Industrial

By End-User

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Clinical Testing Laboratories
Blood Banks
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- The rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the flow cytometry market include Becton, Dickinson and Company, Danaher Corporation (Beckman Coulter), Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec, Sysmex Corporation, bioMerieux, Cytek Biosciences, and Apogee Flow Systems Ltd. among others.

Key Developments

In April 2024, Beckman Coulter Life Sciences introduced the QbD1200+ Total Organic Carbon (TOC) Analyzer. This new instrument simplifies and accelerates the analysis of pharmaceuticals and biopharmaceuticals, providing more robust data. It features streamlined validation processes and encrypted data reporting, ensuring compliance with 21 CFR Part 11 regulations and major global pharmacopeia standards.
In March 2024, Beckman Coulter Life Sciences announced the launch of the CytoFLEX nano Flow Cytometer, a specialized instrument designed for research purposes that significantly enhances the capabilities of flow cytometry. It can detect particles as small as 40 nm, marking a significant improvement over traditional flow cytometers, which typically have higher detection thresholds. This enhanced capability allows researchers to analyze smaller biological entities, such as extracellular vesicles (EVs), that are crucial for understanding various biological processes and diseases.
In January 2024, Cytek Biosciences, Inc. agreed with the Centre for Genomic Regulation (CRG) and Pompeu Fabra University (UPF). This collaboration aims to foster technological innovation and expedite discoveries for the scientific community.
In January 2023, METAFORA Biosystems announced the launch of METAflow, its digital flow cytometry platform, into the Research Use Only (RUO) market. METAflow features a sophisticated suite of unsupervised algorithms that streamline the analysis process, making it accessible to users of all skill levels, from novices to experts. This cloud-based software automates the multidimensional clustering of flow cytometry data, representing a significant improvement over existing solutions that may not be as effective, regardless of the user's data processing abilities.

Why Purchase the Report?

To visualize the global flow cytometry market segmentation based on product type, technology, application, end-user, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the flow cytometry market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in excel consisting of key products of all the major players.

The global flow cytometry market report would provide approximately 70 tables, 65 figures, and 184 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Incidence of Chronic Diseases and Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. High Equipment Costs
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Reagents and Consumables*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Antibodies
- 6.2.4. Assays and kits
- 6.2.5. Others
6.3. Instruments
- 6.3.1. Cell Analyzers
- 6.3.2. Cell Sorters
6.4. Software
6.5. Accessories
6.6. Services

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Cell-Based *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Bead-Based

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Research *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.2.3. Drug Discovery
- 8.2.4. Stem Cell Research
- 8.2.5. Immunology Studies
- 8.2.6. Apoptosis Analysis
- 8.2.7. Cell Sorting and Viability Assessments
8.3. Clinical
- 8.3.1. Cancer Detection
- 8.3.2. Organ Transplantation
- 8.3.3. Immunodeficiency Disorders
- 8.3.4. Hematology
8.4. Industrial

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Pharmaceutical & Biotechnology Companies*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Academic & Research Institutes
9.4. Hospitals & Clinical Testing Laboratories
9.5. Blood Banks
9.6. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Becton, Dickinson and Company *
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Danaher Corporation (Beckman Coulter)
12.3. Thermo Fisher Scientific Inc.
12.4. Agilent Technologies, Inc.
12.5. Bio-Rad Laboratories, Inc.
12.6. Miltenyi Biotec
12.7. Sysmex Corporation
12.8. bioMerieux
12.9. Cytek Biosciences
12.10. Apogee Flow Systems Ltd.

LIST NOT EXHAUSTIVE